Cihanbeylerden, M. Et Al. 2023. Evaluation of disease control after SARS-CoV-2 infection and/or vaccination in patients with NSAID-exacerbated respiratory disease. Annual Hybrid Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI) , (Hamburg, Germany), 52.

Cihanbeylerden, M., Bostan, O. C., Tuncay, G., Damadoglu, E., KARAKAYA, G., & Kalyoncu, A. F., (2023). Evaluation of disease control after SARS-CoV-2 infection and/or vaccination in patients with NSAID-exacerbated respiratory disease . Annual Hybrid Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI) (pp.52). Hamburg, Germany

Cihanbeylerden, M. Et Al. "Evaluation of disease control after SARS-CoV-2 infection and/or vaccination in patients with NSAID-exacerbated respiratory disease," Annual Hybrid Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), Hamburg, Germany, 2023

Cihanbeylerden, M. Et Al. "Evaluation of disease control after SARS-CoV-2 infection and/or vaccination in patients with NSAID-exacerbated respiratory disease." Annual Hybrid Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI) , Hamburg, Germany, pp.52, 2023

Cihanbeylerden, M. Et Al. (2023) . "Evaluation of disease control after SARS-CoV-2 infection and/or vaccination in patients with NSAID-exacerbated respiratory disease." Annual Hybrid Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI) , Hamburg, Germany, p.52.

@conferencepaper{conferencepaper, author={M. Cihanbeylerden Et Al. }, title={Evaluation of disease control after SARS-CoV-2 infection and/or vaccination in patients with NSAID-exacerbated respiratory disease}, congress name={Annual Hybrid Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI)}, city={Hamburg}, country={Germany}, year={2023}, pages={52} }